Click for best price
AntiHypertensive Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 40890 million
|
Forecast Market size by 2029 |
US$ 48250 million
|
| Growth Rate |
CAGR of 2.4% |
Number of Pages |
78 Pages |
The global Anti-Hypertensive Drugs market was valued at US$ 40890 million in 2022 and is projected to reach US$ 48250 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Anti-Hypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Hypertensive Drugs. This report contains market size and forecasts of Anti-Hypertensive Drugs in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Diuretics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Hypertensive Drugs include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, AstraZeneca and Daiichi Sankyo Company Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Hypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Hypertensive Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Type, 2022 (%)
- Diuretics
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Beta Blockers
- Alpha Blockers
- Vasodilators
- Renin Inhibitors
Global Anti-Hypertensive Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anti-Hypertensive Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Hypertensive Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Hypertensive Drugs revenues share in global market, 2022 (%)
Key companies Anti-Hypertensive Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Hypertensive Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Pfizer
- Johnson & Johnson
- Sanofi
- Lupin
- Ranbaxy Laboratories
- Merck
- AstraZeneca
- Daiichi Sankyo Company Limited
- Takeda Pharmaceutical
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Anti-Hypertensive Drugs, market overview.
- Chapter 2: Global Anti-Hypertensive Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Anti-Hypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Anti-Hypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Anti-Hypertensive Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Hypertensive Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 40890 million
|
| Forecast Market size by 2029 |
US$ 48250 million
|
| Growth Rate |
CAGR of 2.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Hypertensive Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Hypertensive Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Hypertensive Drugs Overall Market Size
2.1 Global Anti-Hypertensive Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Hypertensive Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Hypertensive Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Hypertensive Drugs Players in Global Market
3.2 Top Global Anti-Hypertensive Drugs Companies Ranked by Revenue
3.3 Global Anti-Hypertensive Drugs Revenue by Companies
3.4 Global Anti-Hypertensive Drugs Sales by Companies
3.5 Global Anti-Hypertensive Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Hypertensive Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Hypertensive Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Hypertensive Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Hypertensive Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Hypertensive Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Hypertensive Drugs Market Size Markets, 2022 & 2029
4.1.2 Diuretics
4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors
4.1.4 Angiotensin Receptor Blockers (ARBs)
4.1.5 Calcium Channel Blockers
4.1.6 Beta Blockers
4.1.7 Alpha Blockers
4.1.8 Vasodilators
4.1.9 Renin Inhibitors
4.2 By Type - Global Anti-Hypertensive Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Hypertensive Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Hypertensive Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Hypertensive Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Hypertensive Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Hypertensive Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Hypertensive Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Hypertensive Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Anti-Hypertensive Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Hypertensive Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Hypertensive Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Hypertensive Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Hypertensive Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Hypertensive Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Hypertensive Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Hypertensive Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Hypertensive Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Hypertensive Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Hypertensive Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Hypertensive Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Hypertensive Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Hypertensive Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Hypertensive Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Hypertensive Drugs Sales, 2018-2029
6.4.3 US Anti-Hypertensive Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Hypertensive Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Hypertensive Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Hypertensive Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Hypertensive Drugs Sales, 2018-2029
6.5.3 Germany Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.4 France Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Hypertensive Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Hypertensive Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Hypertensive Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Hypertensive Drugs Sales, 2018-2029
6.6.3 China Anti-Hypertensive Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Hypertensive Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Hypertensive Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Hypertensive Drugs Market Size, 2018-2029
6.6.7 India Anti-Hypertensive Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Hypertensive Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Hypertensive Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Hypertensive Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Hypertensive Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Hypertensive Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Hypertensive Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Hypertensive Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Hypertensive Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Anti-Hypertensive Drugs Major Product Offerings
7.1.4 Novartis Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Anti-Hypertensive Drugs Major Product Offerings
7.2.4 Pfizer Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Anti-Hypertensive Drugs Major Product Offerings
7.3.4 Johnson & Johnson Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Anti-Hypertensive Drugs Major Product Offerings
7.4.4 Sanofi Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Lupin
7.5.1 Lupin Company Summary
7.5.2 Lupin Business Overview
7.5.3 Lupin Anti-Hypertensive Drugs Major Product Offerings
7.5.4 Lupin Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Lupin Key News & Latest Developments
7.6 Ranbaxy Laboratories
7.6.1 Ranbaxy Laboratories Company Summary
7.6.2 Ranbaxy Laboratories Business Overview
7.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Major Product Offerings
7.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Ranbaxy Laboratories Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-Hypertensive Drugs Major Product Offerings
7.7.4 Merck Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Anti-Hypertensive Drugs Major Product Offerings
7.8.4 AstraZeneca Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Daiichi Sankyo Company Limited
7.9.1 Daiichi Sankyo Company Limited Company Summary
7.9.2 Daiichi Sankyo Company Limited Business Overview
7.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Major Product Offerings
7.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Daiichi Sankyo Company Limited Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
8 Global Anti-Hypertensive Drugs Production Capacity, Analysis
8.1 Global Anti-Hypertensive Drugs Production Capacity, 2018-2029
8.2 Anti-Hypertensive Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Hypertensive Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Hypertensive Drugs Supply Chain Analysis
10.1 Anti-Hypertensive Drugs Industry Value Chain
10.2 Anti-Hypertensive Drugs Upstream Market
10.3 Anti-Hypertensive Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Hypertensive Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Hypertensive Drugs in Global Market
Table 2. Top Anti-Hypertensive Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Hypertensive Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Hypertensive Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Hypertensive Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Hypertensive Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Hypertensive Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Anti-Hypertensive Drugs Product Type
Table 9. List of Global Tier 1 Anti-Hypertensive Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Hypertensive Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Hypertensive Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Hypertensive Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Hypertensive Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Hypertensive Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Hypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Hypertensive Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Hypertensive Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Hypertensive Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Hypertensive Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Hypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Hypertensive Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Hypertensive Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Hypertensive Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Hypertensive Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Hypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Hypertensive Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Hypertensive Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Anti-Hypertensive Drugs Product Offerings
Table 48. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Anti-Hypertensive Drugs Product Offerings
Table 52. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Anti-Hypertensive Drugs Product Offerings
Table 56. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Anti-Hypertensive Drugs Product Offerings
Table 60. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Lupin Company Summary
Table 63. Lupin Anti-Hypertensive Drugs Product Offerings
Table 64. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Lupin Key News & Latest Developments
Table 66. Ranbaxy Laboratories Company Summary
Table 67. Ranbaxy Laboratories Anti-Hypertensive Drugs Product Offerings
Table 68. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Ranbaxy Laboratories Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Anti-Hypertensive Drugs Product Offerings
Table 72. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Anti-Hypertensive Drugs Product Offerings
Table 76. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Daiichi Sankyo Company Limited Company Summary
Table 79. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Offerings
Table 80. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Daiichi Sankyo Company Limited Key News & Latest Developments
Table 82. Takeda Pharmaceutical Company Summary
Table 83. Takeda Pharmaceutical Anti-Hypertensive Drugs Product Offerings
Table 84. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Takeda Pharmaceutical Key News & Latest Developments
Table 86. Anti-Hypertensive Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Anti-Hypertensive Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Anti-Hypertensive Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Anti-Hypertensive Drugs Production by Region, 2024-2029 (K Units)
Table 90. Anti-Hypertensive Drugs Market Opportunities & Trends in Global Market
Table 91. Anti-Hypertensive Drugs Market Drivers in Global Market
Table 92. Anti-Hypertensive Drugs Market Restraints in Global Market
Table 93. Anti-Hypertensive Drugs Raw Materials
Table 94. Anti-Hypertensive Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Anti-Hypertensive Drugs Downstream
Table 96. Anti-Hypertensive Drugs Downstream Clients in Global Market
Table 97. Anti-Hypertensive Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Hypertensive Drugs Segment by Type in 2022
Figure 2. Anti-Hypertensive Drugs Segment by Application in 2022
Figure 3. Global Anti-Hypertensive Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Hypertensive Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Hypertensive Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Hypertensive Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Hypertensive Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Hypertensive Drugs Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Hypertensive Drugs Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Anti-Hypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Hypertensive Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Hypertensive Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Hypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Hypertensive Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Hypertensive Drugs by Region, 2022 VS 2029
Figure 54. Anti-Hypertensive Drugs Industry Value Chain
Figure 55. Marketing Channels
